secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001213900-25-034184
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen amends East West Bank loan: maturity to Jan 2027, rate 10%, $3.99M principal
--------------------------------------------------------------------------------

- Maturity extended from Apr 15, 2025 to Jan 15, 2027; interest rate fixed at 10% per annum (from variable).
- Principal amount reduced to $3,991,127.50; payments: $1M due Jun 1, 2025; $1M Jul 15; $500K Oct 15; then $500K quarterly.
- $250,000 reserve account required for interest payments; default rate increases by 5 percentage points (max legal rate).
- Lender agrees to release deed of trust on real property collateral upon full repayment or pledge of cash collateral.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390025034184/0001213900-25-034184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390025034184/ea0239064-8k_nkgen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-034184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer